Schroder Investment Management Group Sarepta Therapeutics, Inc. Transaction History
Schroder Investment Management Group
- $94.4 Billion
- Q1 2025
A detailed history of Schroder Investment Management Group transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 60,351 shares of SRPT stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,351
Previous 5,523
992.72%
Holding current value
$1.1 Million
Previous $671,000
473.92%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SRPT
# of Institutions
486Shares Held
91.4MCall Options Held
1.39MPut Options Held
1.15M-
Black Rock Inc. New York, NY10.3MShares$188 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$165 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$165 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$74.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$61.3 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...